Katherine Scott

Associate Director

Katherine has a broad range of experience in pharmaceutical market access, including roles in both government and consulting. She spent several years working within Canadian public payers, contributing to the operations of the public drug programs in New Brunswick and Alberta. Katherine played a key role in numerous pan-Canadian Pharmaceutical Alliance (pCPA) negotiations and the implementation of product listing agreements, as well as drug plan initiatives such as the Alberta Biosimilar Initiative. Transitioning to consulting in September 2021, Katherine joined MORSE where she leverages her extensive background in economics and hands-on experience in public drug plans and the pCPA. Her insights are instrumental in crafting effective market access strategies, guiding clients through complex reimbursement landscapes.

Developing strategies that consider the challenges and perspective of the public payer is crucial to achieving success in the Canadian market. I am eager to support clients by applying my distinct frame of reference to the increasingly complex and ever evolving market landscape.
Katherine remains dedicated to delivering tailored solutions that align with MORSE’s commitment to achieving optimal outcomes in pharmaceutical market access. Her dual perspective—from government policymaking to consulting—positions her as a trusted advisor in navigating the evolving healthcare landscape.

Katherine can be reached at Katherine@morseconsulting.ca or 204-720-1174. 

Get In touch
Katherine Scott, Consultant at MORSE Consulting Inc.